In MCF-7 breast cancer cells, this compound acts by inhibiting epithelial–mesenchymal transition (EMT), negatively modulating β-catenin nuclear translocation and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling [39]. Here, AKT1 is linked to breast cancer.